Since PUFAs cannot be synthesized de novo, mesenchymal cancers regulate the ratio of PLs with PUFAs and MUFAs by upregulating ACSL4, fatty acid desaturase 2 (FADS2), and ELOVL fatty acid elongase 5 (ELOVL5). This evidence concerns the gene ACSL4 and cancer.